CREATING DRUGS AT THE SPEED OF AI
Live / Applied — Response to non-final action entered (as of 08 Dec 2025)
What this means for you
Not registered yet, but its 15 Apr 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99137351
- Mark type
- Stylized text
- Filed
- 15 Apr 2025
- Attorney of record
- Tiffany D. Gehrke
Goods and services
- Class 040 — Treatment of materials: Biotechnological services in the nature of custom biomanufacturing of pharmaceutical preparations, namely, custom production and purification of biotechnological and pharmaceutical preparations, namely, hormones, antibodies, and proteins; biotechnological services in the nature of custom biomanufacturing of pharmaceutical preparations, namely, custom production of cell lines to produce proteins, namely, hormones, cytokines, antibodies and antibody fragments
- Class 042 — Scientific and technological services: Scientific and technological consulting services relating to producing, assaying, and purifying biotechnological products; research and development in the pharmaceutical and biotechnology fields; biotechnical and pharmacological laboratory services for biomanufacturing, namely, scientific and technological research relating to the production of biotechnological products for use in preparing pharmaceutical preparations; scientific and technological research , namely, scientific research, development, analysis, producing, testing, scientific research, development, analysis, producing, testing, in the field of biotechnology, namely, production of biotechnological products for use in preparing pharmaceutical preparations, and scientific research consultation related thereto; scientific research, namely, carrying out feasibility studies relating to the production of biotechnological products for use in preparing pharmaceutical preparations; development of pharmaceutical preparations, medicines and medicaments; technological consultancy services, namely, technological consultation in the field of biotechnology, namely, production of biotechnological products for use in preparing pharmaceutical preparations; Bioinformatics research services, namely, analyzing complex biological data through the use of artificial intelligence, and testing and evaluation of biologics through artificial intelligence; development of pharmaceutical preparations in the nature of computer assisted biologics design involving the use of artificial intelligence technology; Biotechnological services, namely, development of biotechnological and pharmaceutical preparations, namely, hormones, antibodies, and proteins; biotechnological services, namely, development of cell lines to produce proteins, namely, hormones, cytokines, antibodies and antibody fragments
Owner
- Absci Corporation, Vancouver, WA, US
Prosecution history
- 09 Dec 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 09 Dec 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 08 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 08 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 10 Sept 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 10 Sept 2025 — NON-FINAL ACTION E-MAILED
- 10 Sept 2025 — NON-FINAL ACTION WRITTEN
- 10 Sept 2025 — ASSIGNED TO EXAMINER
- 11 Jul 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 15 Apr 2025 — APPLICATION FILING RECEIPT MAILED
- 15 Apr 2025 — NEW APPLICATION ENTERED